It was a busy week in the biotech sector with lots of regulatory and pipeline updates. Among bigwigs, Gilead Sciences, Inc.

Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...

The global opioid use disorder treatment market is poised for significant growth, with an expected market size of USD 3.07 ...

A recent report from MarketsAndMarkets projected that the global gastric cancer market accounted for USD 3.01 billion in 2023 and is expected to reach USD 18.43 billion by 2034 with a CAGR of 17.92% ...

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

GSK's drive to resurrect its multiple myeloma ... Blenrep won accelerated FDA approval in 2020 as a fourth-line or later treatment for multiple myeloma, becoming the first BCMA-directed therapy ...

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted approach.

Valink Therapeutics, a biopharmaceutical company focused on discovering and developing innovative bispecific antibody-drug conjugates (bsADCs) to transform the treatment of cancer and other diseases, ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

Independent Analysis of Annual Sales Forecasts by Distribution Channel (Retail Pharmacies, Online Pharmacies, Other ...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the appointment of ...

The meningococcal B vaccine Bexsero is funded for people aged 13-25 who are entering their first year of close-living ...